Advances in allergic skin disease: Omalizumab is a promising therapy for urticaria and angioedema
Authors:
- 1 January 2009
- journal article
- other
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 123 (1) , 273-274
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insects in 2007Journal of Allergy and Clinical Immunology, 2008
- Successful treatment of cholinergic urticaria with anti‐immunoglobulin E therapyAllergy, 2008
- Successful treatment of 3 patients with recurrent idiopathic angioedema with omalizumabJournal of Allergy and Clinical Immunology, 2007
- Effect of omalizumab on patients with chronic urticariaAnnals of Allergy, Asthma & Immunology, 2007
- Successful treatment of cold-induced urticaria/anaphylaxis with anti-IgEJournal of Allergy and Clinical Immunology, 2006